Based on positive results from the Radiation Therapy Oncology Group (RTOG) 85-01 trial, the conventional nonsurgical treatment of esophageal carcinoma...
More »Based on positive results from the Radiation Therapy Oncology Group (RTOG) 85-01 trial, the conventional nonsurgical treatment of esophageal carcinoma...
More »Based on positive results from the Radiation Therapy Oncology Group (RTOG) 85-01 trial, the conventional nonsurgical treatment of esophageal carcinoma...
More »Compared with surgery alone, the triple combination of chemotherapy, radiation therapy, and surgery is associated with a more than doubling of overall...
More »ROCHESTER, MINNESOTA—
A phase II study from the North
Central Cancer Treatment Group
(NCCTG) showed that oxaliplatin
(Eloxatin) combined with...
More »Gastric cancer is more common than esophageal cancer in Western countries
but is less fatal. More than 27,000 new cases of gastric cancer will be...
More »Although still relatively uncommon in Western countries, esophageal cancer is
fatal in the vast majority of cases. In the United States, an estimated...
More »Esophageal cancer is a rare but highly virulent malignancy in the
United States, and adenocarcinoma of the esophagus has had the most
rapid rate of...
More »Esophageal cancer frequently expresses cyclooxygenase-2 (COX-2)
enzyme. In preclinical studies, COX-2 inhibition results in decreased
cell...
More »The 30 reports in this special supplement to Oncology News
International represent highlights of ongoing major clinical trials and new
research...
More »
Showing 31 - 40 of 64 results.